Publication Beamlines Strategic Pillar
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of racemic benserazide hydrochloride Form I, C10H16N3O5Cl. Powder Diffraction , 1-7. 10.1017/s0885715624000496. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Thomas N. (2024). Crystal structure of gepirone, C19H29N5O2. Powder Diffraction , 1-6. 10.1017/s0885715624000514. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of repotrectinib, C18H18FN5O2. Powder Diffraction , 1-6. 10.1017/s0885715625100882. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of palovarotene, C 27 H 30 N 2 O 2 . Powder Diffraction , 1-6. 10.1017/s0885715625100869. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). Crystal structure of givinostat hydrochloride monohydrate Form I, C 24 H 28 N 3 O 4 Cl(H 2 O). Powder Diffraction , 1-6. 10.1017/s0885715625100559. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom (2025). A proposed crystal structure of fruquintinib Form I, C21H19N3O5. Powder Diffraction , 1-7. 10.1017/s0885715625100808. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Powder pattern and hydrogen bonding in the crystal structure of phenelzine sulfate, C 8 H 14 N 2 (SO 4 ). Powder Diffraction , 1-5. 10.1017/s0885715625000545. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of niraparib tosylate monohydrate Form I, (C 19 H 21 N 4 O)(C 7 H 7 O 3 S)(H 2 O). Powder Diffraction , 1-9. 10.1017/s0885715625000181. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of ethynodiol diacetate, C 24 H 32 O 4 . Powder Diffraction , 1-6. 10.1017/s0885715625100729. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of trametinib dimethyl sulfoxide, C26H23FIN5O4(C2H6OS). Powder Diffraction 40(2) , 162-167. 10.1017/s0885715625000168. BXDS-WLE Health
Kaduk, James A.; Dosen, Anja; Blanton, Tom N. (2025). Crystal structure of aprocitentan Form A, C16H14Br2N6O4S. Powder Diffraction 40(2) , 168-174. 10.1017/s088571562500017x. BXDS-WLE Health
Kaduk, James; Dosen, Anja; Blanton, Tom (2025). Crystal structure of anisomycin, C 14 H 19 NO 4 . Powder Diffraction , 1-6. 10.1017/s0885715625100791. BXDS-WLE Health
Kalantarian, S. Marzieh; Slovenský, Peter; Wang, Zhiqiang; Romanovski, Valentin; Romanovskaia, Elena et al. (2025). Effect of Nanoparticle Size on Cysteine‐Gold Surface Interactions. Particle and Particle Systems Characterization . 10.1002/ppsc.202400230. HXMA Materials
Kalliokoski, Tuomo; Kettunen, Henna; Kumpulainen, Esa; Kettunen, Emilia; Thieulin-Pardo, Gabriel et al. (2023). Discovery of novel methionine adenosyltransferase 2A (MAT2A) allosteric inhibitors by structure-based virtual screening. Bioorganic and Medicinal Chemistry Letters 94, 129450. 10.1016/j.bmcl.2023.129450. [PDB: 8p1t, 8p1v] CMCF-ID Health
Kalugin, Denis; Bahig, Jumanah; Shoker, Ahmed; Abdelrasoul, Amira (2023). Heparin-Immobilized Polyethersulfone for Hemocompatibility Enhancement of Dialysis Membrane: In Situ Synchrotron Imaging, Experimental, and Ex Vivo Studies. Membranes 13(8) , 718. 10.3390/membranes13080718. BMIT-BM Health